Independent consultant, Sheffield, UK.
ALTEX. 2024;41(4):503-524. doi: 10.14573/altex.2410111.
Despite the importance of the animal testing issue, there has been little presentation in the scientific literature of the trends in animal use. This is crucial to resolve, particularly if we are to measure the impact of initiatives to reduce and replace animal experiments that were recently announced in Europe and the USA. For the first time, the number of animals used between 2002 and 2022 are presented for the EU, key animal-using countries in Europe (the UK, France and Germany), and North America (the USA and Canada). Animal testing is on a slow decrease in the EU, 11% in the last 20 years, but animal use in the UK, France and Germany is at similar levels as it was in 2002. Notably there has been a decrease in the production of genetically altered animals in the UK and a decrease in regulatory testing in the EU. Animal use in Canada has been steadily growing, and figures for the USA are still incomplete as laboratory-bred rodents and some other species are not counted. However, globally, the use of non-animal methods in biomedical research is increasing exponentially; this accelerated in the mid-2010s. The UK appears to be the leader in this field. The technological, regulatory, political and economic factors that might explain these trends are discussed.
尽管动物试验问题很重要,但在科学文献中很少有关于动物使用趋势的介绍。这一点至关重要,如果我们要衡量最近在欧洲和美国宣布的减少和替代动物实验的倡议的影响,就必须解决这个问题。本文首次介绍了欧盟、欧洲主要的动物使用国(英国、法国和德国)以及北美(美国和加拿大)在 2002 年至 2022 年间使用的动物数量。欧盟的动物试验呈缓慢减少趋势,在过去 20 年中减少了 11%,但英国、法国和德国的动物使用量与 2002 年相似。值得注意的是,英国的基因改造动物的产量有所下降,欧盟的监管测试也有所减少。加拿大的动物使用量一直在稳步增长,而美国的数据仍不完整,因为实验室饲养的啮齿动物和其他一些物种未被计入。然而,在全球范围内,生物医学研究中非动物方法的使用正在呈指数级增长;这一趋势在 2010 年代中期加速。英国似乎在这一领域处于领先地位。本文讨论了可能解释这些趋势的技术、监管、政治和经济因素。